Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.
about
Shiga toxin 2 targets the murine renal collecting duct epitheliumPathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome.Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.Shiga toxin pathogenesis: kidney complications and renal failure.Bacterial RNA:DNA hybrids are activators of the NLRP3 inflammasomeAcute kidney injury: what part do toll-like receptors play?Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.Mouse models of Escherichia coli O157:H7 infection and shiga toxin injectionA novel mechanism of bacterial toxin transfer within host blood cell-derived microvesiclesThe glucocorticoid receptor: a revisited target for toxinsComparative Effect of Recombinant Shiga Toxin in Induction of Pro- and Anti-Apoptotic Markers and Inflammatory Cytokines in Epithelial and Monocytic Cells.A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine modelPodocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.
P2860
Q24652310-C7F81881-D413-48F7-A1C1-CF968E0100B4Q33338331-9DD40DD7-53F6-459B-AFF7-7010F99F7285Q33346344-63989859-5FF4-4626-BF72-90E370340BB3Q33348633-39C6A86E-AB9D-4299-BECC-1A5C96940503Q33357487-313A61DC-19F4-45AA-A2E7-F8121D51EF3EQ33364401-CB6C36D6-60A2-4931-89BE-C464667435C7Q33372623-5BAA6416-2291-4767-A74F-F8E41FE0742EQ33380705-7DCB916C-53E7-479E-992D-2AD9AC392A8AQ33382197-B4CC8848-0A32-4007-B5DB-6D0A44323440Q33394010-2939980C-0006-49A9-B2F7-60A64A0D25DCQ33397459-600B6366-E1C8-404D-8C8E-4FBD57F9AD5BQ33397541-19E1FCF2-877C-4089-ABEE-03B5BB26EB9EQ33415311-8AF0B7D8-63CD-4091-A3A2-8DEAFCDFA8C1Q33800669-628420AE-1016-441D-A0CA-5DBB111C2746Q33952458-BF01E8A5-2B24-4CFF-A89D-540EFB410EF5Q34119320-512942DB-F6E8-48A6-822D-ACC033C66E6DQ34497115-E9BA9267-05C6-4EE4-A4EC-442EC7DD910DQ35125841-C87ABCF9-0EBF-4DCB-80CB-7720C31662FCQ35155828-E47AE655-6E1C-4C43-99C0-FAA92C426609Q36828069-63A19BE4-B495-4CDA-BA02-8D7A2956CDBCQ37190873-743F3747-34F9-4610-A95B-36A60E78FD5FQ45990632-BFE0D2A5-F76E-4EE0-AC23-3E370EAD1249Q55516340-3EDF60C2-3E3E-408F-B613-87E3133B98F3
P2860
Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@ast
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@en
Pretreatment of mice with lipopolysaccharide
@nl
type
label
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@ast
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@en
Pretreatment of mice with lipopolysaccharide
@nl
prefLabel
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@ast
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@en
Pretreatment of mice with lipopolysaccharide
@nl
P2093
P2860
P1476
Pretreatment of mice with lipo ...... ts on Shiga toxin-2 lethality.
@en
P2093
F Alves-Rosa
G C Fernández
G Fernández-Alonso
P2860
P356
10.1046/J.1365-2249.2000.01103.X
P577
2000-01-01T00:00:00Z